att,description,beta.npdr.age,pval.npdr.age,p.adj.npdr.age
ARHGEF4,rho guanine nucleotide exchange factor 4,6.18,3.39E-10,2.01E-06
C11orf21,chromosome 11 open reading frame 21,5.31,5.58E-08,3.30E-04
STX4,syntaxin 4,5.28,6.55E-08,3.87E-04
PTPRE,"protein tyrosine phosphatase, receptor type e",5.19,1.06E-07,6.28E-04
UHRF1,ubiquitin like with phd and ring finger domains 1,5.15,1.32E-07,7.78E-04
AGAP2,"arfgap with gtpase domain, ankyrin repeat and ph domain 2",4.90,4.78E-07,0.003
C16orf45,chromosome 16 open reading frame 45,4.90,4.95E-07,0.003
DPH3P1,diphthamide biosynthesis 3 pseudogene 1,4.75,1.06E-06,0.006
ACP5,"acid phosphatase 5, tartrate resistant",4.65,1.68E-06,0.010
CBLL1,cbl proto-oncogene like 1,4.65,1.72E-06,0.010
QRICH1,glutamine rich 1,4.56,2.59E-06,0.015
RAB7A,"rab7a, member ras oncogene family",4.53,2.93E-06,0.017
PSMD5,"proteasome 26s subunit, non-atpase 5",4.48,3.86E-06,0.023
CBY1,"chibby family member 1, beta catenin antagonist",4.47,4.02E-06,0.024
CACNA1C,calcium voltage-gated channel subunit alpha1 c,4.46,4.08E-06,0.024
TUBA4B,tubulin alpha 4b,4.41,5.16E-06,0.031
WNT8B,wnt family member 8b,4.40,5.59E-06,0.033
PMEL,premelanosome protein,4.36,6.60E-06,0.039
EFR3B,efr3 homolog b,4.34,7.36E-06,0.044
MYLPF,"myosin light chain, phosphorylatable, fast skeletal muscle",4.33,7.45E-06,0.044
NSG1,neuronal vesicle trafficking associated 1,4.33,7.66E-06,0.045
CHKA,choline kinase alpha,4.33,7.67E-06,0.045